Hypoxia enhances proliferation, angiogenesis, metastasis, chemoresistance, and
radioresistance of hepatocellular carcinoma (HCC); suppresses differentiation and …

Traditional treatments for intermediate or advanced stage hepatocellular carcinoma (HCC)
such as transarterial chemoembolization (TACE) and anti-angiogenesis therapies were …

Hepatocellular carcinoma (HCC) is potentially curable with hepatic resection or
transplantation. Few patients are eligible for resection, and many face a long wait for donor …

Four patients with inoperable hepatocellular carcinoma were treated with a magnetic
targeted carrier bound to doxorubicin (MTC-DOX) by using a joint magnetic resonance (MR) …

Hepatitis B virus X protein (HBx) of the hepatitis B virus was strongly implicated in
angiogenesis and metastasis during hepatocarcinogenesis. Here, we explored the …

PURPOSE: To evaluate the per-nodule efficacy of superselective transarterial
chemoembolization of hepatocellular carcinomas (HCCs). MATERIALS AND METHODS …

Transcatheter arterial chemoembolization (TACE) is extensively used in the treatment of
hepatocellular carcinoma (HCC), but its efficacy is usually limited to secondary tumor …

This review focuses upon interactions and potential therapeutic targets in the 'vicious
cycle'between hypoxia and neoangiogenesis following treatment of hepatocellular …

We investigated the phenotype of hepatocellular carcinoma (HCC) in livers removed during
transplantation after local ablation therapy by transarterial chemoembolization (TACE). This …

Hepatocellular carcinoma (HCC) causes a significant health burden globally and its impact
is expected to increase in the coming years. Intermediate stage HCC, as defined by the …